Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice

Pharmacology Biochemistry and Behavior

Volumn 88, Issue 4, 2008, Pages 385-392

  Haghparast, Abbas ^a   Khani, Abbas ^a   Naderi, Nima ^a   Alizadeh, Amir Mohammad ^a   Motamedi, Fereshteh ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dependence; Morphine; Muscarinic receptor; Nicotine; Nicotinic receptor; Tolerance

Indexed keywords

ATROPINE; HEXAMETHONIUM; MECAMYLAMINE; MORPHINE; MUSCARINIC RECEPTOR BLOCKING AGENT; NALOXONE; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; JUMPING; MALE; MORPHINE ADDICTION; MORPHINE TOLERANCE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; ANIMALS; ATROPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; GANGLIONIC BLOCKERS; HEXAMETHONIUM COMPOUNDS; MALE; MECAMYLAMINE; MICE; MORPHINE; MORPHINE DEPENDENCE; MUSCARINIC ANTAGONISTS; NALOXONE; NARCOTIC ANTAGONISTS; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PAIN MEASUREMENT; SUBSTANCE WITHDRAWAL SYNDROME;

MUS;

EID: 37249078851     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2007.09.010     Document Type: Article

References (33)

1. Balfour D.J.K. The effect of nicotine on brain neurotransmitter systems. Pharmacol Ther 16 (1982) 269-282
2. Balfour D.J.K. The neurochemical mechanisms underlying nicotine tolerance and dependence. In: Pratt J. (Ed). The biological bases of drug tolerance and dependence (1991), Academic Press, New York 121-151
3. Berrendero F., Kieffer B.L., and Maldonado R. Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in μ-opioid receptor knock-out mice. J Neurosci 22 (2002) 10935-10940
4. Bhargava V.K., and Saha L. Cholinergic mechanism in imipramine and morphine antinociception. Indian J Pharmacol 33 (2001) 212-214
5. Biala G., Budzynska B., and Kruk M. Naloxone precipitates nicotine abstinence syndrome and attenuates nicotine-induced antinociception in mice. Pharmacol Rep 57 (2005) 755-760
6. Biala G., and Weglinska B. On the mechanism of cross-tolerance between morphine-and nicotine-induced antinociception: involvement of calcium channels. Prog Neuro-Psychopharmacol Biol Psychiatry 30 (2006) 15-21
7. Bie B., and Pan Z.Z. Increased glutamate synaptic transmission in the nucleus raphe magnus neurons from morphine-tolerant rats. Mol Pain 1 (2005) 7
8. Brase D.A., Tseng L.F., Loh H.H., and Way E.L. Cholinergic modification of naloxone-induced jumping in morphine dependent mice. Eur J Pharmacol 26 (1974) 1-8
9. Clarke P.B.S. Dopaminergic mechanisms in the locomotor stimulant effects of nicotine. Biochem Pharmacol 40 (1990) 1427-1432
10. Concas A., Sogliano C., Porcu P., Marra C., Brundu A., and Biggio G. Neurosteroids in nicotine and morphine dependence. Psychopharmacology 186 (2006) 281-292
11. Davenport K.E., Houdi A.A., and Van Loon G.R. Nicotine protects against mu-opioid receptor antagonism by beta-funaltrexamine: evidence for nicotine-induced release of endogenous opioids in brain. Neurosci Lett 113 (1990) 40-46
12. Eiden L.E., Giraud P., Dave J.R., Hotchkiss A.J., and Affolter H.U. Nicotinic receptor stimulation activates enkephalin release and biosynthesis in adrenal chromaffin cells. Nature 312 (1984) 661-663
13. Giorguieff-Chesselet M.F., Kemel M.L., Wandscheer D., and Glowinski J. Regulation of dopamine release by presynaptic nicotinic receptors in rat striatal slices: effect of nicotine in a low concentration. Life Sci 25 (1979) 1257-1261
14. Gomaa A.A., Mohamed L.H., and Ahmed H.N. Modification of morphine-induced analgesia, tolerance and dependence by bromocriptine. Eur J Pharmacol 170 (1989) 129-135
15. Goodman F.R. Effects of nicotine on distribution and release of 14C-norepinephrine and 14C-dopamine in rat brain striatum and hypothalamus slices. Neuropharmacology 13 (1974) 1025-1032
16. Gossop M., Powell J., Grey S., and Hajek P. What do opiate addicts and cigarette smokers mean by "craving"? A pilot study. Drug Alcohol Depend 26 (1990) 85-87
17. Houdi A.A., Pierzchala K., Marson L., Palkovits M., and Van Loon G.R. Nicotine-induced alteration in Tyr-Gly-Gly and Met-enkephalin in discrete brain nuclei reflects altered enkephalin neuron activity. Peptides 12 (1991) 161-166
18. Imperato A., Mulas A., and Di Chiara G. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol 132 (1986) 337-338
19. Jhamandas K., and Dickinson G. Modification of precipitated morphine and methadone abstinence in mice by acetylcholine antagonists. Nat New Biol 245 (1973) 219-221
20. Jhamandas K., Sutak M., and Bell S. Modification of precipitated morphine withdrawal syndrome by drugs affecting cholinergic mechanisms. Eur J Pharmacol 24 (1973) 296-305
21. Lee P.W., and Lee Y.M. Transcriptional regulation of μ opioid receptor gene by cAMP pathway. Mol Pharmacol 64 (2003) 1410-1418
22. Malin D.H., Lake J.R., Carter V.A., Cunningham J.S., Hebert K.M., Conrad D.L., and Wilson O.B. The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat. Psychopharmacology 115 (1994) 180-184
23. Malin D.H., Lake J.R., Carter V.A., Cunningham J.S., and Wilson O.B. Naloxone precipitates nicotine abstinence syndrome in the rat. Psychopharmacology 112 (1993) 339-342
24. Marshall I., and Grahame-Smith D.G. Evidence against a role of brain 5-ydroxytryptamine in the development of physical dependence upon morphine in mice. J Pharmacol Exp Ther 179 (1971) 634-641
25. Nestler E.J. Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol Sci 25 (2004) 210-218
26. Nordberg A., Romanelli L., Sundwall A., Bianchi C., and Beani L. Effect of acute and subchronic nicotine treatment on cortical acetylcholine release and on nicotinic receptors in rats and guinea-pigs. Br J Pharmacol 98 (1989) 71-78
27. Rosecrans J.A., Hendry J.S., and Hong J.S. Biphasic effects of chronic nicotine treatment on hypothalamic immunoreactive beta-endorphin in the mouse. Pharmacol Biochem Behav 23 (1985) 141-143
28. Simons C.T., Cuellar J.M., Moore J.A., Pinkerton K.E., Uyeminami D., Carstens M.I., and Carstens E. Nicotinic receptor involvement in antinociception induced by exposure to cigarette smoke. Neurosci Lett 389 (2005) 71-76
29. Walters C.L., Cleck J.N., Kuo Y.C., and Blendy J.A. μ-Opioid receptor and CREB activation are required for nicotine reward. Neuron 46 (2005) 933-943
30. Wewers M.E., Dhatt R.K., Snively T.A., and Tejwani J.A. The effect of chronic administration of nicotine on antinociception, opioid receptor binding and met-enkephalin levels in rats. Brain Res 822 (1999) 107-113
31. Zarrindast M.R., and Farzin D. Nicotine attenuates naloxone-induced jumping behaviour in morphine-dependent mice. Eur J Pharmacol 298 (1996) 1-6
32. Zarrindast M.R., Khoshayand M.R., and Shafaghi B. The development of cross-tolerance between morphine and nicotine in mice. Eur Neuropsychopharmacol 9 (1999) 227-233
33. Zarrindast M.R., and Moghaddampour E. Opposing influences of D-1 and D-2 dopamine receptors activation on morphine-induced antinociception. Arch Int Pharmacodyn Ther 300 (1989) 37-50